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Coronary myocardial bridge: an innocent bystander?
Abstract Myocardial bridge (MB) or tunneled coronary 
artery is an inborn abnormality, which implicates a systolic 
vessel compression with a persistent mid-late diastolic 
diameter reduction. Myocardial bridges are often observed 
during coronary angiography with an incidence of 0.5%–
5.5%. The most involved coronary artery is the left anterior 
descending artery followed by the diagonal branches, the 
right coronary artery, and the left circumfl ex. The overall 
long-term prognosis is generally benign. However, several 
risk or precipitating factors (e.g., high heart rate, left ven-
tricular hypertrophy, decreased peripheral vascular resis-
tance) may trigger symptoms (most frequently angina). 
Herein, we describe two cases of symptomatic myocardial 
bridge, where medical treatment (i.e., inotropic negative 
drug) and coronary stenting were successfully utilized to 
treat this pathology. We also focus on the clinical presenta-
tion, and the diagnostic and therapeutic modalities to cor-
rectly manage this frequently observed congenital coronary 
abnormality, underlining the fact that in cases of typical 
angina symptoms without any signifi cant coronary artery 
disease, MB should be considered as a possible differential 
diagnosis.
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Introduction
Myocardial bridge (MB) or tunneled coronary artery is 
an inborn abnormality, which implicates a systolic vessel 
compression with a persistent mid-late diastolic diameter 
reduction.1 This entity was fi rst described in 19512 and angi-
ographically documented in 1960.3 The fi rst described case 
series in 19764 reported an incidence of 0.5%–5.5% of MB 
observed during coronary angiography; a percentage which 
was later confi rmed by more recent angiography reports.5–9 
However, contrary to what is observed during coronary 
angiography, at necropsy the reported incidence of MB 
could be much higher (up to 55%).10
Fifty percent of patients presenting with MB have con-
comitant coronary artery disease (CAD) in terms of athero-
sclerotic lumen vessel narrowing,4,11,12 especially at the 
proximal edge of the MB probably due to a turbulent fl ow 
phenomenon.2,6,13 More than two thirds of these patients 
have systolic vessel compression of >50% of the lumen 
diameter.4,11 Several risk factors implicated in symptoms 
development are the high heart rate, the myocardial con-
tractility state, the presence of a left ventricle (LV) hyper-
trophy, a decreased peripheral vascular resistance, and the 
length and localization of the MB.1,14
Even if only 15% of the normal coronary fl ow occurs 
during systole, this percentage is increased during acceler-
ated heart rate, thereby increasing the signifi cance of the 
MB.14 In fact, in cases of MB with a signifi cant persistent 
diastolic diameter reduction, the coronary fl ow reserve 
(CFR) may decrease to 2–2.5 (normal range >3).7
The length of MB may vary from 4 up to 40 mm and its 
thickness between 1 and 4 mm.4,8,10 The most involved coro-
nary artery is the left anterior descending (LAD) artery 
followed by the diagonal branches, the right coronary artery 
(RCA), and the left circumfl ex (LCX).1,13 Herein, we 
describe two cases of symptomatic myocardial bridge, where 
medical treatment and coronary stenting were successfully 
utilized to treat this pathology.
Case reports
Case 1
A 73-year-old hyperlipidemic patient known since 18 years 
previously for a myocardial bridge in the LAD was referred 
to our center for treatment of moderate drug-resistant 
angina pectoris. The coronary angiography did not show any 
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signifi cant CAD (Fig. 1A), which could explain the symp-
toms of the patient and confi rm the presence of a mild MB 
on the mid part of the LAD. In this segment the intracoro-
nary (i.c.) fractional fl ow reserve (FFR) at rest and after 
i.c. adenosine injection was normal (0.91). Therefore, we 
decided to perform an i.c. isoprenaline provocative test 
aiming to increase heart rate and contractility. At heart rate 
of 80 beats/min the patient developed angina symptoms 
with ST depression on the surface ECG, and the angiogra-
phy revealed a severe compression of the mid-LAD with a 
pathological FFR (0.71) (Fig. 1B).
Confronted with this clinical and angiographical picture 
we decided to stent the mid-LAD segment with a Cypher 
Stent (Cordis, Miami Lakes, FL, USA) (3.0/33 mm at 18 atm) 
with fi nal abolition of the MB (angiography and FFR nor-
malized) (Fig. 1C) and of his angina symptoms on long-term 
(i.e., 18 months) follow-up.
Case 2
A 68-year-old hypertensive, hyperlipidemic patient was 
referred to our center for unstable angina of several weeks’ 
duration. The patient, known for a three-vessel CAD, 
already percutaneously revascularized a few years before, 
showed an anterolateral ischemia on exercise 201Thallium 
myocardial scintigraphy. The coronary angiography showed 
no signifi cant progression of the known CAD (Fig. 2A). 
However, probably aggravated by the administration of i.c. 
nitrates, an important MB on the mid-LAD associated with 
angina symptoms was observed during the catheterization 
(Fig. 2B). After the i.c. administration of 1 mg verapamil this 
MB completely disappeared (Fig. 2C) and the symptoms 
regressed, therefore we decided to continue an intensive 
calcium channel antagonist (CCA) treatment (360 mg/day 
verapamil) with favorable long-term (i.e., 30 months) 
Fig. 1. A Lateral view of the left anterior descending artery (LAD) 
without any signifi cant coronary vessel narrowing. B Left anterior 
descending artery during the isoprenaline i.c. provocative test showing 
a mid-LAD complete obliteration responsible for the angina symptoms 
of the patient (arrow). C Final result after stenting of the LAD, showing 
no systolic vessel compression at rest and after i.c. isoprenaline injec-
tion (arrow)
Fig. 2. A Left anterior oblique view of the LAD showing no signifi cant 
coronary artery disease on the LAD. B After the i.c. nitrates injection, 
an important systolic vessel compression appeared on the mid part of 
the LAD (arrow). C Disappearance of the LAD vessel compression 
after i.c. injection of 1 mg verapamil (arrow)
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outcome (i.e., no symptoms, no recurrent myocardial 
ischemia at 9 months follow-up scintigraphy).
Discussion
Clinical presentation of MB
Superfi cial MBs are often asymptomatic and probably only 
the deep intramural course may provoke cardiac symp-
toms.13 A myocardial bridge may damage the coronary 
endothelium, producing platelet aggregation and vasospasm 
leading to acute coronary syndromes (ACS).15 Even if most 
of the time MBs are incidental fi ndings during angiography, 
a various spectrum of clinical presentation has already been 
reported, including ACS, myocardial infarction, sudden 
cardiac death, ventricular septum rupture, myocardial stun-
ning, and malignant arrythmias.1,13,16–20
Men are more involved than women and usually patients 
presenting with symptomatic MB are 10 years younger than 
a similar cohort of patients presenting “standard” CAD. 
Angina pectoris, occurring in up to 70% of the cases, is the 
cardinal symptom in patients presenting deep intramural 
MB. These patients may also present pathological functional 
stress tests especially in the LV anterior wall. Ischemia is 
mainly due to the systolic vessel compression and the per-
sistent diastolic lumen diameter reduction which, associated 
with an increased and abnormal coronary fl ow, triggers 
symptoms.6,7
Diagnosis
Myocardial bridges may be confi rmed by quantitative coro-
nary angiography (QCA), by intravascular ultrasound 
(IVUS), or by i.c. Doppler measurements.7,9,12
QCA. If QCA shows a >70% minimal lumen diameter 
vessel narrowing during systole or a >35% during diastole, 
signifi cant MB is present.1
IVUS. In cases of MB, IVUS analysis shows a typical 
pattern (half moon phenomenon) with phasic systolic vessel 
compression and persistent diastolic vessel diameter 
reduction.9
Intracoronary Doppler. By i.c. Doppler, the increased 
velocity with its typical fl ow pattern is characteristic of MB 
(i.e., systolic fl ow reversal, reduced CFR, diastolic fi ngertip 
phenomenon).1,9 However, in doubtful cases, some i.c. pro-
vocative tests may be helpful in posing the diagnosis.21–24 To 
further evaluate the clinical relevance of a moderate MB 
observed during coronary angiography the FFR measure-
ment in this specifi c region may also be of great interest in 
the decision making of when and how to treat this coronary 
milking phenomenon.
Provocative tests. There are several provocative tests that 
may be performed in the catheterization laboratories in 
order to better detect clinical relevant MB. To stimulate the 
heart (inotropism+chronotropism), physical effort during 
catheterization, or a dobutamine or isoprenaline perfusion 
are usually utilized according to the local expertise. To test 
the coronary vasoreactivity and an eventual endothelial 
dysfunction, a cold test alone or in combination with an 
acetylcholine or methylergometrine test may also be 
performed.24 These pharmacological provocative tests are, 
however, not complication free and should therefore be 
utilized only in case of a high clinical suspicion (presence of 
a MB in the territory of the suffering myocardium) and not 
routinely in all cases of patients presenting with angina and 
no signifi cant CAD.25
Treatment modalities
The fi rst-line treatment modality of symptomatic MB should 
be the administration of inotropic negative drugs (i.e., beta-
blockers or CCA).26,27 Nitrates, which increase the degree of 
the systolic compression, should be avoided,28,29 and in case 
of drug-resistant MB, percutaneous (fi rst described in 
1995)8,24,30 or surgical (i.e., myotomy or bypass graft) should 
be proposed.31,32 Due to the procedural safety and the 
reported long-term effi cacy of stenting symptomatic MB,8 
this minimally invasive procedure seems to be the fi rst-line 
treatment in case of drug-resistant MB. However, some 
caution should be taken, especially if considering the fact 
that large case series utilizing stents (especially drug-eluting 
stents) for the treatment of symptomatic MB are still 
lacking.
Prognosis
The overall long-term prognosis is generally benign,5 even 
if some authors are less optimistic regarding a conservative 
approach of symptomatic MB.16–18
Conclusion
Despite myocardial bridges being quite often observed 
during coronary angiography, they are only rarely clinically 
relevant. Our two cases illustrate two different clinical pre-
sentations of this pathology, underlining two of the possible 
treatment modalities in case of symptomatic MB.
In case of typical angina symptoms without any signifi -
cant CAD revealed by angiography but the presence of a 
mild coronary MB, the possibility of an increased coronary 
compression during effort as the cause of the angina symp-
toms should be evoked, especially in concomitance with 
the above-mentioned risk or precipitating factors. Thus, the 
eventuality that this mild MB is clinically relevant should 
be confi rmed and actively tested during the cardiac cath-
eterization (i.e., i.c. provocative tests). In fact, the i.c. 
nitrates injection, usually utilized for coronary vasodilata-
tion, may unmask a symptomatic MB (see Case 2), which 
in doubtful cases may be further accentuated utilizing 
several other provocative tests (e.g., i.c. isoprenaline or 
dobutamine injection) aimed to increase heart rate and 
inotropism, and thus the coronary milking phenomenon 
(see Case 1).
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Negative inotropic drugs should be the fi rst-line treat-
ment modality of these symptomatic MBs. However, in case 
of recurrence, despite optimal medical treatment, direct 
stenting of the compressed coronary segment can be safely 
attempted, even if more data confi rming its long-term effi -
cacy will be necessary before stating that this percutane-
ously performed procedure should replace surgery.
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